Lucid Diligence Brief: T-Therapeutics Series A extension to $91m
Lucid Diligence Brief: T-Therapeutics Series A extension to $91m Professional…
Lucid Diligence Brief: General Proximity and Daiichi Sankyo multi-target induced-proximity oncology deal
Lucid Diligence Brief: General Proximity and Daiichi Sankyo multi-target…
Lucid Diligence Brief: Chiesi partners with Aliada (AbbVie) on BBB platform for LSDs
Lucid Diligence Brief: Chiesi partners with Aliada on BBB platform for LSDs…
Lucid Diligence Brief: myTomorrows $29 million funding to scale AI-enabled clinical-trial recruitment
Lucid Diligence Brief: myTomorrows $29 million funding to scale AI-enabled…
Lucid Diligence Brief: INBRAIN and Microsoft partner on agentic AI for precision neurology and BCI
Lucid Diligence Brief: INBRAIN and Microsoft partner on agentic AI for…
Lucid Diligence Brief: Galecto acquires Damora Therapeutics
Lucid Diligence Brief: Galecto acquires Damora Therapeutics Professional…
Lucid Diligence Brief: Iambic raises $100M+ for AI drug discovery
Lucid Diligence Brief: Iambic raises $100M+ for AI drug discovery Professional…
AI in Healthcare and Digital Health Today—November 10, 2025
This week’s AI in Healthcare and Digital Health brief distills AI-driven…
Lucid Diligence Brief: SanegeneBio and Lilly RNAi collaboration in metabolic diseases
Lucid Diligence Brief: SanegeneBio and Lilly RNAi collaboration in metabolic…
Lucid Diligence Brief: Amae Health $25M Series B
Lucid Diligence Brief: Amae Health $25M Series B Professional audiences only.…
Lucid Diligence Brief: Braveheart Bio launches with $185M Series A
Lucid Diligence Brief: Braveheart Bio launches with $185M Series A Professional…
Lucid Diligence Brief: Azalea Therapeutics launches with $82M financing
Lucid Diligence Brief: Azalea Therapeutics launches with $82M financing…